[Platelet-rich plasma combined with autologous cancellous bone : An alternative therapy for persistent non-union?]

Unfallchirurg. 2011 Nov;114(11):998-1006. doi: 10.1007/s00113-010-1836-2.
[Article in German]

Abstract

Background: In addition to a stabile osteosynthesis autologous cancellous bone graft remains an essential therapy option in persistent non-union. Despite this therapy regimen persistent non-union can occasionally occur. The aim of this study was to evaluate the treatment of persistent non-union with a combination of platelet-rich plasma (PRP) and autologous cancellous bone.

Material and methods: In this prospective study 17 patients with persistent non-union of long bones were treated by a combination of PRP and autologous iliac crest bone. Inclusion criteria were a minimum of one previously failed cancellous bone transplantation and an atrophic non-union persisting for 6-14 months (mean 9 months). The patients were examined clinically and radiologically at intervals of 3, 6 and 9 months postoperatively.

Results: After an average time of 17 months (range 15-23 months) the patients were treated by a combination of PRP and autologous cancellous bone. In all cases the non-union was successfully treated and osseous bridging was found radiologically after an average of 5 months (range 4-7 months) without any complications.

Conclusion: The combination of PRP and autologous cancellous bone appears to be a safe and effective method for treatment of persistent non-union. The use of PRP does not result in substantial additional costs. Allergies and graft versus host reactions are not expected because of the autologous origin.

MeSH terms

  • Adult
  • Aged
  • Bone Transplantation / methods*
  • Combined Modality Therapy
  • Female
  • Fractures, Malunited / diagnostic imaging*
  • Fractures, Malunited / therapy*
  • Humans
  • Male
  • Middle Aged
  • Platelet Transfusion / methods*
  • Platelet-Rich Plasma*
  • Radiography
  • Treatment Outcome
  • Young Adult